Impact of COVID-19 on Management of Laryngeal/Oropharyngeal Neoplasms.

COVID and cancer impact of COVID impact of lockdown lockdown and cancer

Journal

Craniomaxillofacial trauma & reconstruction
ISSN: 1943-3875
Titre abrégé: Craniomaxillofac Trauma Reconstr
Pays: United States
ID NLM: 101541666

Informations de publication

Date de publication:
Jun 2021
Historique:
entrez: 17 5 2021
pubmed: 18 5 2021
medline: 18 5 2021
Statut: ppublish

Résumé

A retrospective cohort study. The world was unprecedentedly struck by the new coronavirus in December 2019. Consequently, lockdown measures were imposed by many governments. Health-care services were reserved for emergencies and malignancies. Nevertheless, many patients who urgently needed these services did not present. This study estimates the impact of COVID-19 and lockdown measures on the patients' flow in the outpatient clinic (OPC) and the operations for laryngeal and/or oropharyngeal neoplasms. This study is a retrospective cohort study performed in otolaryngology department of a tertiary care hospital which is a major referral center. All patients who attended the OPC and all operations performed for laryngeal and/or oropharyngeal neoplasms were counted from February 1, 2020 to May 31, 2020 and compared with the previous year as a reference. In 2020, the number of patients attending the otolaryngology OPC and the laryngeal and/or oropharyngeal surgeries showed a major drop, especially after imposing the lockdown measures. The total number of these operations in April and May 2019 dropped by 79% for the same period in 2020. An estimate of 79% of patients, who had been presenting for laryngeal and/or oropharyngeal neoplasms, did not show up due to indirect COVID-19 effect.

Identifiants

pubmed: 33995837
doi: 10.1177/1943387520963823
pii: 10.1177_1943387520963823
pmc: PMC8108102
doi:

Types de publication

Journal Article

Langues

eng

Pagination

157-161

Informations de copyright

© The Author(s) 2020.

Déclaration de conflit d'intérêts

Declaration of Conflicting Interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Références

East Mediterr Health J. 2020 May 21;26(5):499-502
pubmed: 32538441
N Engl J Med. 2020 Jan 2;382(1):60-72
pubmed: 31893516
Eye (Lond). 2020 Jul;34(7):1187-1188
pubmed: 32382143
Int J Infect Dis. 2020 Jul;96:219-221
pubmed: 32389851
Oncology. 2016;91(1):13-23
pubmed: 27245686
J Autoimmun. 2020 May;109:102433
pubmed: 32113704
BMJ. 2020 Apr 30;369:m1711
pubmed: 32354699
BMJ. 2020 Apr 1;369:m1327
pubmed: 32238354
J Travel Med. 2020 May 18;27(3):
pubmed: 32181488

Auteurs

Mohamed Abd Elmottaleb Sabaa (MAE)

ENT Department, Cairo University, El Manial, Cairo, Egypt.

T M Algarf (TM)

ENT Department, Cairo University, El Manial, Cairo, Egypt.

Classifications MeSH